Experts envision greater cardiac imaging role for PET

03/5/2013 | MolecularImaging.net

PET is gaining momentum as an effective and preferred approach over SPECT for myocardial perfusion imaging in diagnosing coronary artery disease, thanks to improved resolution and other factors. However, experts say there are barriers to the use of PET in routine clinical practice, including pre-approval requirements, which could reduce access to testing. "We may be placing very high barriers for people to get access to some tests that are quite appropriate," said Dr. Marcelo Di Carli, chief of nuclear medicine and molecular imaging at Boston's Brigham and Women's Hospital. "While you are improving appropriateness, you also are reducing access for patients who need these studies.”

View Full Article in:

MolecularImaging.net

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations